South African dyslipidaemia guideline consensus statement

  • EQ Klug South African Heart Association (SA Heart) Lipid and Atherosclerosis Society of Southern Africa (LASSA)
  • FJ Raal South African Heart Association (SA Heart) Lipid and Atherosclerosis Society of Southern Africa (LASSA)
  • AD Marais South African Heart Association (SA Heart) Lipid and Atherosclerosis Society of Southern Africa (LASSA)
  • M-R Taskinen South African Heart Association (SA Heart) Lipid and Atherosclerosis Society of Southern Africa (LASSA)
  • AJ Dalby South African Heart Association (SA Heart) Lipid and Atherosclerosis Society of Southern Africa (LASSA)
  • C Schamroth South African Heart Association (SA Heart) Lipid and Atherosclerosis Society of Southern Africa (LASSA)
  • N Rapeport South African Heart Association (SA Heart) Lipid and Atherosclerosis Society of Southern Africa (LASSA)
  • D Jankelow South African Heart Association (SA Heart) Lipid and Atherosclerosis Society of Southern Africa (LASSA)
  • DJ Blom South African Heart Association (SA Heart) Lipid and Atherosclerosis Society of Southern Africa (LASSA)
  • R Catsicas South African Heart Association (SA Heart) Lipid and Atherosclerosis Society of Southern Africa (LASSA)
  • DA Webb South African Heart Association (SA Heart) Lipid and Atherosclerosis Society of Southern Africa (LASSA)
DOI: https://doi.org/10.24170/9-2-1855

Abstract

The European Society of Cardiology together with the European Atherosclerosis Society published updated dyslipidaemia guidelines in 2011. SA Heart and the Lipid and Atherosclerosis Society of Southern Africa officially adopt these guidelines. This statement adapts aspects of the guidelines to the South African situation. Using the updated Framingham risk charts, interventional strategies are based according to the cardiovascular risk score and low-density lipoprotein cholesterol (LDL-C) levels. The Framingham risk score refers to the 10-year risk of any cardiovascular event, and includes four categories of risk. Treatment targets are those of the European guidelines. The LDL-C goal is 1.8mmol/l for the very high-risk group (>30%), 2.5mmol/l for the high-risk group (15 - 30%), and 3mmol/l for those below 15% risk. Intensive management of dyslipidaemia in South Africa will significantly reduce the cardiovascular disease health burden.
Published
2017-04-03
Issue
Vol. 9 No. 2 (2012): Autumn
Section
Guidelines

Copyright (c) 2017 SA Heart Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This journal is an open access journal, and the authors and journal should be properly acknowledged, when works are cited.

Authors may use the publishers version for teaching purposes, in books, theses, dissertations, conferences and conference papers. 

A copy of the authors’ publishers version may also be hosted on the following websites:

  • Non-commercial personal homepage or blog.
  • Institutional webpage.
  • Authors Institutional Repository. 

The following notice should accompany such a posting on the website: “This is an electronic version of an article published in SAHJ, Volume XXX, number XXX, pages XXX–XXX”, DOI.  Authors should also supply a hyperlink to the original paper or indicate where the original paper (http://www.journals.ac.za/index.php/SAHJ) may be found. 

Authors publishers version, affiliated with the Stellenbosch University will be automatically deposited in the University’s’ Institutional Repository SUNScholar.

Articles as a whole, may not be re-published with another journal.

Copyright Holder: SA Heart Journal

The following license applies:

Attribution CC BY-NC-ND 4.0